Medpace Holdings, Inc. - Common Stock (MEDP)

Historical Holders from Q3 2016 to Q3 2025

Symbol: MEDP on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 28,414,670
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 23,961,178
Holdings value: $12,311,524,811
% of all portfolios: 0.02%
Number of holders: 661
Number of buys: 314
Number of sells: -330
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Troendle August J.	20%	+2.5%	$3,389,756,472	-$200,043,884	5,682,934	-5.6%	August J. Troendle	26 Nov 2025

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	23,961,178	$12,311,524,811	-$1,139,217,023	$91,197,244	$53,230,796	$514.16	661
2025 Q2	26,383,560	$8,288,435,409	+$333,924,717	$30,754,476	$17,005,823	$313.86	594
2025 Q1	25,343,081	$7,716,238,673	-$9,715,142	$21,674,197	$14,151,422	$304.69	576
2024 Q4	25,331,795	$8,417,259,527	+$78,993,016	$23,058,094	$24,687,020	$332.23	578
2024 Q3	25,078,556	$8,379,228,697	-$156,643,937	$69,088,811	$14,278,616	$333.80	576
2024 Q2	25,123,043	$10,346,630,119	+$74,318,631	$32,680,298	$15,938,595	$411.85	618
2024 Q1	24,952,951	$10,082,317,534	+$220,628,799	$47,325,965	$70,200,855	$404.15	584
2023 Q4	82,618	$25,359,626	+$11,291,032			$306.53	5
2023 Q3	23,796,843	$5,763,431,549	-$27,498,819	$12,324,417	$15,520,533	$242.13	477
2023 Q2	23,686,331	$5,688,939,821	-$272,260,092	$6,028,267	$20,102,229	$240.17	451
2023 Q1	24,850,086	$4,672,067,690	+$107,834,945	$6,957,850	$3,685,780	$188.05	408
2022 Q4	24,140,143	$5,127,902,204	-$275,370,306	$10,831,644	$8,878,785	$212.41	409
2022 Q3	25,720,926	$4,042,308,837	-$77,992,547	$6,601,000	$19,599,000	$157.17	334
2022 Q2	26,304,137	$3,926,446,107	-$149,862,394	$6,283,051	$14,039,255	$149.67	324
2022 Q1	27,262,176	$4,459,390,206	-$288,891,808	$7,591,000	$18,650,000	$163.59	331
2021 Q4	28,477,854	$6,196,066,680	-$16,366,403	$3,333,000	$11,889,000	$217.64	375
2021 Q3	28,611,077	$5,415,037,207	+$189,253,038	$9,840,000	$24,509,000	$189.28	330
2021 Q2	27,556,169	$4,867,256,718	-$59,750,344	$8,885,000	$14,942,000	$176.63	319
2021 Q1	27,974,530	$4,592,245,582	+$104,139,266	$1,591,000	$9,564,000	$164.05	313
2020 Q4	27,659,725	$3,848,156,121	+$92,415,519	$7,875,000	$7,600,000	$139.20	304
2020 Q3	26,856,323	$3,001,153,305	-$129,210,746	$1,397,000	$4,402,000	$111.75	302
2020 Q2	28,343,774	$2,635,284,602	+$18,280,774	$3,646,000	$3,711,000	$93.02	264
2020 Q1	28,126,126	$2,064,730,654	-$34,973,290	$3,308,000	$4,992,000	$73.38	260
2019 Q4	28,839,389	$2,418,322,620	+$12,861,008	$5,274,000	$3,901,000	$84.06	242
2019 Q3	28,494,699	$2,389,936,343	-$75,067,867	$6,614,000	$7,842,000	$84.04	258
2019 Q2	29,668,023	$1,923,105,392	+$236,417,964	$7,870,000	$3,571,000	$65.42	216
2019 Q1	27,098,751	$1,596,708,125	-$95,602,241	$9,017,000	$9,273,000	$58.97	224
2018 Q4	28,649,042	$1,505,488,597	+$237,400,235	$2,671,000	$4,539,000	$52.93	211
2018 Q3	24,075,036	$1,443,015,978	+$617,354,522	$3,738,000	$5,488,000	$59.91	205
2018 Q2	13,906,568	$597,916,964	+$189,676,125	$0	$1,428,000	$43.00	141
2018 Q1	9,415,446	$328,713,487	+$38,062,865	$237,000	$1,578,000	$34.91	108
2017 Q4	8,566,251	$303,468,112	+$73,429,567			$36.26	111
2017 Q3	6,389,162	$203,789,709	+$6,862,523			$31.90	84
2017 Q2	6,307,151	$182,910,653	-$10,958,173			$29.00	76
2017 Q1	6,616,348	$197,508,880	-$7,558,176			$29.85	76
2016 Q4	7,258,363	$261,791,100	+$49,003,112			$36.07	78
2016 Q3	6,172,151	$179,832,168	+$179,832,199			$29.86	68